Stock Track | HealthEquity Soars 5.43% in Pre-Market on Analyst Target Price Hikes

Stock Track12-04

HealthEquity (HQY) surged 5.43% in pre-market trading, reflecting strong investor sentiment following positive analyst actions.

The rally was primarily driven by JP Morgan raising its target price for HealthEquity to $129 from $126, signaling confidence in the company's growth prospects. Additionally, BTIG maintained its bullish $130 target, while Citizens reiterated a "Market Outperform" rating, further supporting the stock's upward momentum.

These analyst actions collectively boosted market optimism, leading to the pre-market surge as traders reacted to the upgraded outlook for HealthEquity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1123664173?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-04 21:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123664173","market":"sg","top_or_hot":-1,"title":"Stock Track | HealthEquity Soars 5.43% in Pre-Market on Analyst Target Price Hikes","media":"Stock Track","content":"<p>HealthEquity (HQY) surged 5.43% in pre-market trading, reflecting strong investor sentiment following positive analyst actions.</p><p>The rally was primarily driven by JP Morgan raising its target price for HealthEquity to $129 from $126, signaling confidence in the company's growth prospects. Additionally, BTIG maintained its bullish $130 target, while Citizens reiterated a \"Market Outperform\" rating, further supporting the stock's upward momentum.</p><p>These analyst actions collectively boosted market optimism, leading to the pre-market surge as traders reacted to the upgraded outlook for HealthEquity.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | HealthEquity Soars 5.43% in Pre-Market on Analyst Target Price Hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | HealthEquity Soars 5.43% in Pre-Market on Analyst Target Price Hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-12-04 21:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HealthEquity (HQY) surged 5.43% in pre-market trading, reflecting strong investor sentiment following positive analyst actions.</p><p>The rally was primarily driven by JP Morgan raising its target price for HealthEquity to $129 from $126, signaling confidence in the company's growth prospects. Additionally, BTIG maintained its bullish $130 target, while Citizens reiterated a \"Market Outperform\" rating, further supporting the stock's upward momentum.</p><p>These analyst actions collectively boosted market optimism, leading to the pre-market surge as traders reacted to the upgraded outlook for HealthEquity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HQY","symbol_name":"HealthEquity","start_time":0,"source_url":"","article_id":"1123664173","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123664173","pubTimestamp":1764855156,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"HealthEquity (HQY) surged 5.43% in pre-market trading, reflecting strong investor sentiment following positive analyst actions.The rally was primarily driven by JP Morgan raising its target price for...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HQY":"HealthEquity"},"translate_title":"个股追踪|分析师上调目标价HealthEquity盘前飙升5.43%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HQY":1},"content_text":"HealthEquity (HQY) surged 5.43% in pre-market trading, reflecting strong investor sentiment following positive analyst actions.The rally was primarily driven by JP Morgan raising its target price for HealthEquity to $129 from $126, signaling confidence in the company's growth prospects. Additionally, BTIG maintained its bullish $130 target, while Citizens reiterated a \"Market Outperform\" rating, further supporting the stock's upward momentum.These analyst actions collectively boosted market optimism, leading to the pre-market surge as traders reacted to the upgraded outlook for HealthEquity.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1123664173","isCrawlerRequest":true}